FDA independent appeals board would be created under PhRMA reform legislation.
This article was originally published in The Tan Sheet
Executive Summary
FDA INDEPENDENT APPEALS BOARD WOULD BE CREATED under draft legislative language being circulated by the Pharmaceutical & Research Manufacturers of America. The PhRMA proposal suggests that the HHS secretary would be directed to establish standing panels of non-government experts "for the purpose of hearing appeals by individuals who have exhausted their informal appeals within FDA and wish to contest the action or failure to act by FDA in a particular matter. The secretary shall establish an appeal procedure that assures immediate access to such a panel and prompt conclusions and recommendations by the panel."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning